Stelara biosimilars formulary placement and related provider guidance
Customize your policy alerts
Sign up for all sanford health plan policy alerts
Know when sanford health plan releases new policies or updates existing guidance.
Monitor payer policy activity
Governance of Sanford Health Plan's formulary changes for Stelara and newly preferred biosimilars, who this affects (providers prescribing Stelara or its biosimilars and Sanford members), and related portal/authorization guidance for providers.
Three biosimilars to Stelara (Selarsdi, Wezlana, Yesintek) were added to the Sanford Health Plan formulary as preferred options.
No prior authorization is required for patients currently treated with Stelara to be switched to one of the biosimilars; exceptions to remain on Stelara require prior authorization.
Guidance encouraging providers to begin new patients on biosimilars and to discuss switching current patients to biosimilars.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.